Pfizer’s stock hit a new 52-week low but recovered to close higher following global uncertainty caused by the tariff war and fears of a global recession. Despite a decline in COVID revenues, Pfizer’s non-COVID operational revenues improved in 2024, driven by key products in oncology. The company faces challenges such as declining COVID product sales and upcoming patent expirations, but remains attractive from a valuation standpoint and is making a comeback with a strong performance in 2024.
Full Article
Targeting DOGE, labor group puts up billboards warning of heat deaths at national parks
Extreme Heat Wave and National Park ConcernsAn early-season heat wave is affecting the West, with extreme temperatures expected, particularly in Death Valley, where highs could exceed 115 degrees. More Perfect Union's billboard campaign aims to raise awareness about the impact of layoffs at DOGE and cuts to national parks, urging the public to take precautions during the heat, as stated by Death Valley's acting deputy superintendent, Abigail Wines. The campaign seeks to provoke debate about...
Read more